Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial

BACKGROUND: Anti-leishmanial drug regimens that include a single dose AmBisome® could be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the appropriate single dose is unknown. METHODOLOGY: A multi-centre, open-label, non-inferiority, randomized controlled tria...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khalil, Eltahir A. G., Weldegebreal, Teklu, Younis, Brima M., Omollo, Raymond, Musa, Ahmed M., Hailu, Workagegnehu, Abuzaid, Abuzaid A., Dorlo, Thomas P. C., Hurissa, Zewdu, Yifru, Sisay, Haleke, William, Smith, Peter G., Ellis, Sally, Balasegaram, Manica, EL-Hassan, Ahmed M., Schoone, Gerard J., Wasunna, Monique, Kimutai, Robert, Edwards, Tansy, Hailu, Asrat
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3894173/
https://ncbi.nlm.nih.gov/pubmed/24454970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0002613
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares